Increased fibrosis progression rates in hepatitis C patients carrying the prothrombin G20210A mutation

AIM: To examine whether hepatitis C virus (HCV)-infected patients who carry hypercoagulable mutations suffer from increased rates of liver fibrosis. METHODS: We analyzed DNA samples of 168 HCV patients for three common hypercoagulable gene mutations: prothrombin 20210 (PT20210), factor V Leiden (FV...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Maharshak, Nitsan, Halfon, Philippe, Deutsch, Varda, Peretz, Hava, Berliner, Shlomo, Fishman, Sigal, Zelber-Sagi, Shira, Rozovski, Uri, Leshno, Moshe, Oren, Ran
Formato: Artigo
Lenguaje:Inglês
Publicado: Baishideng Publishing Group Co., Limited 2011
Materias:
Brief Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3236579/
https://ncbi.nlm.nih.gov/pubmed/22174551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v17.i45.5007
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares